Xiaoxiao Cai
Papers
1
Total Citations
40
H-Index
1
About
Xiaoxiao Cai is a pioneering researcher at the intersection of nanomedicine, DNA nanotechnology, and immunotherapy, with a focus on developing intelligent therapeutic systems for critical inflammatory diseases. Her most notable contribution is the design of a DNA-based nanorobot capable of targeting, hitchhiking, and regulating neutrophils to enhance sepsis therapy—a groundbreaking approach published in 2025 that has already garnered 40 citations. This work represents a paradigm shift in sepsis treatment, leveraging the body’s own immune cells as delivery vehicles to precisely modulate inflammation. Cai’s research integrates principles of molecular engineering and cellular biology, demonstrating how programmable DNA nanostructures can interact with living systems in real time. Her innovative strategy not only improves therapeutic efficacy but also minimizes off-target effects, addressing a major challenge in nanomedicine. With a growing citation impact, Cai’s work is poised to influence both fundamental research in DNA nanotechnology and clinical applications for immune-related disorders. Her achievements highlight her as a rising leader in the field, inspiring students and researchers to explore the potential of bioinspired nanorobots for precision medicine.
Research Focus
Key Achievements
Top Papers
- 1